NCT07050043 2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3 Recruiting
Clinical Trials
7 trialsNCT05878028 2024-05-23
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
Henan Cancer Hospital
Phase 2 Recruiting
NCT06208033 2024-01-17
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT05192681 2022-01-14
Tislelizumab as Cross-line Treatment for Advanced NSCLC
Fujian Cancer Hospital
Phase 2 Unknown
NCT01356303 2016-05-13
TAXIS01
National Guard Health Affairs
Phase 2 Suspended
NCT01356368 2014-01-22
Customizing
National Guard Health Affairs
Phase 2 Terminated
NCT01442909 2011-09-29
Pemetrexed Followed by Docetaxel or in Reverse Sequence
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed